Toll-like receptor 7 (TLR7) is a ssRNA receptor that activates dendritic cells and macrophages upon ssRNA binding; however, little is known of its role in CD4+ T cells. We show here that hepatitis C virus (HCV) induces a dose dependent inhibition of cytokine production and expression of activation markers in CD4 T cells, which were restored by a TLR7-specific antagonist. These findings indicate that HCV induces CD4 T cell impairment via TLR7 which may contribute to failure of virus eradication, casting doubts on the use of TLR7 agonists to boost innate immunity in chronic RNA virus infections
Background & Aims: The oral Toll-like receptor (TLR) 7 agonist GS-9620 has antiviral effects in wood...
Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cyt...
Hepatitis C virus (HCV) is an RNA virus that primarily infects the liver, affecting 70 million peopl...
Toll-like receptor 7 (TLR7) is a ssRNA receptor that activates dendritic cells and macrophages upon ...
Background: Hepatitis C virus is considered to be one of the most important devastating causes of ch...
Hepatitis C virus (HCV) interferes with interferon (IFN)-mediated innate immune defenses. Toll-like ...
textabstractBackground: ANA773, an oral prodrug of a small-molecule Toll-like receptor (TLR)7 agonis...
AIM: Hepatitis C virus often establishes chronic infections. Recent studies suggest that viral and b...
Plasmacytoid dendritic cells (pDCs) are innate immune cells with high antiviral activity triggered b...
Background: Hepatitis C virus is considered to be one of the most important devastating causes of ch...
Chronic hepatitis C infection (HCV) activates a systemic cell-mediated immune response characterized...
none12noBACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) and hepatitis C virus (H...
ABESTRACT: Introduction & Objective: Hepatitis C virus (HCV)-infection leads to development of chron...
International audienceBackground & Aims: GS-9620, an oral agonist of toll-like receptor 7 (TLR7), is...
B-cell infection by hepatitis C virus (HCV) has been a controversial topic. To examine whether HCV h...
Background & Aims: The oral Toll-like receptor (TLR) 7 agonist GS-9620 has antiviral effects in wood...
Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cyt...
Hepatitis C virus (HCV) is an RNA virus that primarily infects the liver, affecting 70 million peopl...
Toll-like receptor 7 (TLR7) is a ssRNA receptor that activates dendritic cells and macrophages upon ...
Background: Hepatitis C virus is considered to be one of the most important devastating causes of ch...
Hepatitis C virus (HCV) interferes with interferon (IFN)-mediated innate immune defenses. Toll-like ...
textabstractBackground: ANA773, an oral prodrug of a small-molecule Toll-like receptor (TLR)7 agonis...
AIM: Hepatitis C virus often establishes chronic infections. Recent studies suggest that viral and b...
Plasmacytoid dendritic cells (pDCs) are innate immune cells with high antiviral activity triggered b...
Background: Hepatitis C virus is considered to be one of the most important devastating causes of ch...
Chronic hepatitis C infection (HCV) activates a systemic cell-mediated immune response characterized...
none12noBACKGROUND & AIMS: In patients with chronic hepatitis B virus (HBV) and hepatitis C virus (H...
ABESTRACT: Introduction & Objective: Hepatitis C virus (HCV)-infection leads to development of chron...
International audienceBackground & Aims: GS-9620, an oral agonist of toll-like receptor 7 (TLR7), is...
B-cell infection by hepatitis C virus (HCV) has been a controversial topic. To examine whether HCV h...
Background & Aims: The oral Toll-like receptor (TLR) 7 agonist GS-9620 has antiviral effects in wood...
Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cyt...
Hepatitis C virus (HCV) is an RNA virus that primarily infects the liver, affecting 70 million peopl...